Latest Regulatory News

Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.

The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.

Radiopharm Theranostics has successfully enrolled the second cohort in its Phase 1 trial of 177Lu-RAD204, with the Data Safety Monitoring Committee greenlighting a dose increase to 90mCi for the third cohort. Early results show promising tumor targeting and safety in multiple advanced cancers.

Neurotech International has received a $4.73 million R&D tax incentive refund, reinforcing its clinical development efforts in paediatric neurological disorders. The funds will support ongoing trials and working capital needs.

Resources & Energy Group Limited (ASX, REZ) has announced a substantial JORC-compliant exploration target at its Gigante Grande Central Domain, estimating up to 500,000 ounces of gold. An extensive 8,750m drilling program is planned to commence in early 2026 to test and expand this promising resource.

NT Minerals has disclosed the termination of discussions over a potential share sale agreement following unusual trading activity in its securities. The company confirms compliance with ASX disclosure rules after responding to an ASX query.

Mt Malcolm Mines NL has suspended trading of its M2MOA securities pending regulatory compliance, signaling a cautious pause for investors.

Arika Resources has identified 20 high-priority gold targets at its underexplored Yundamindra South Project using advanced magnetic data, setting the stage for a major exploration push in 2026.

Central Petroleum has agreed to sell its Northern Territory sub-salt exploration permits to Georgina Energy, gaining a 25% equity stake in the helium-focused explorer. The deal refocuses Central on conventional oil and gas while offering shareholders exposure to emerging helium and hydrogen prospects.

Superior Resources Limited has voluntarily suspended trading of its shares pending a Supreme Court hearing on the validation of uncleansed shares, with a prospectus filing expected to follow.

CVC Limited has announced a $50 million offer of unsecured, redeemable notes, combining a reinvestment option for existing holders with a new money offer for fresh investors. The notes will pay a floating quarterly interest and are expected to trade on the ASX under code CVCHB.

Proteomics International Laboratories has secured a $2.2 million Australian Government R&D tax rebate, reinforcing its financial position as it advances a promising pipeline of diagnostic tests based on its proprietary Promarker® technology.